Institute Scholars

Institute Scholar Christopher Barnes won the Protein Science Young Investigator Award for bringing cutting-edge structural biology tools to bear on complex immunological problems.

Institute Scholar Polly Fordyce has been elected into the 2025 AIMBE College of Fellows for her distinguished achievements.

Institute Scholar Polly Fordyce has been elected into the 2025 class of AAAS Fellows for her distinguished contributions in bioengineering.

Rachel Brazil chats with Institute Scholar Paul Mischel about the ring-shaped extrachromosomal DNA that is implicated in many cancers.

Institute Scholar Paul Mischel elected 2025 Fellow of the AACR Academy for his transformative cancer research contributions.

Team led by Institute Scholar Christopher Barnes and Adonis Rubio has designed a series of dual or “bispecific” antibodies, which could potentially resist the evolving SARS-CoV-2.

Bertozzi and Wyss-Coray labs' findings on brain cell sugars may reveal insights into cognitive decline and Alzheimer’s, opening new treatment possibilities.

Institute Scholar Monther Abu-Remaileh one among four Stanford faculty named Sloan Research Fellows.

Stanley Qi and team's “CRISPRKit” is being disseminated to 500 high schoolers in the Bay Area.

Institute Scholar Paul Mischel leads research on the role of ecDNA in cancer.

One of the projects supported through this grant includes Institute Scholar Christopher Barnes' project to identify ways to improve vaccines.

Michael Fischbach, Djenet Bousbaine, and team's findings in mice could translate into a radical, needle-free vaccination approach that would also eliminate reactions.

Protein engineering research is revealing the mysteries of life and enabling advances in pharmaceuticals and other industries.

Institute Scholar Jonathan Z. Long, María Dolores Moya Garzón and team identify a new metabolic pathway that helps explain the molecular links between ketogenic diets.

Tiny circles called ecDNA are critical in cancer development and drug resistance. An international Stanford Medicine-led team publishes landmark studies detailing new findings.

Team led by Institute Scholar Paul Mischel raised hopes of treating some of the most aggressive cases of cancer by targeting small fragments of rogue DNA that help tumors thrive.

Institute Scholar Christopher Barnes on his career journey, challenges, and more!

Institute Scholar Michael Fischbach shares his framework for choosing impactful problems to work on and finding optimal solutions.

The Thiam lab develops new tools/approaches to harness the biophysical mechanisms of cells for improved immune cell-based therapy.